Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 (SnPPIX)
NCT04371822Phase 1Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tin protoporphyrin IX in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by Kafrelsheikh University. Primary endpoints: Lung injury score at 14 days and Serum ferritin at 14 days. Status: unknown.
02
Drugs
tin protoporphyrin IX
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371822.